Biocon Chairperson Kiran Mazumdar-Shaw (Source: Reuters)Biocon Chairperson Kiran Mazumdar-Shaw (Source: Reuters)Drugmaker Biocon has set the price band for an initial public offering (IPO) of its clinical research services arm, Syngene International Ltd, at Rs 240-250 a share, it said on Thursday.
Syngene's IPO shall open for subscription on July 27 and close on July 29, Biocon said in a filing to exchanges.
Biocon said in April that it planned to sell 22 million shares and provide an overallotment option.
Sensex slips 116 pts, Nifty below 26,150 ahead of Christmas break; what’s next? 
TCS, Infosys, HCL Tech, Wipro: Check Q3 results previews, price targets & more
Castrol India shares rise 9% as BP to sell majority stake to Stonepeak 
Zen Technologies stock with revenue CAGR of 45% is down 47% from record high, what's next?
Delhi Metro expansion: Cabinet approves 3 new corridors, 13 stations - full details
What's Hot Today | Prashanth Tapse Tells You The Top Sectors For 2026
India–New Zealand FTA Sealed; Kiwi/Apples/Manuka Honey To Enter Indian Market
“This Nation Is Secular By Culture”: Gadkari On Sanatan Values
From Dhaka To Delhi: Protests Erupt Over Atrocities Against Hindus In Bangladesh
GRAP 4 On Paper, Pollution On Roads: Banned Buses Run Openly In Delhi | AQI | BS-6
Sensex slips 116 pts, Nifty below 26,150 ahead of Christmas break; what’s next? 
Ceinsys Tech shares rise 5%, hit upper circuit; here's why 
Stock picks for 2026: HDFC Bank, Groww, Lenskart, HAL among 12 top bets by Prashanth TapseCastrol India shares rise 9% as BP to sell majority stake to Stonepeak TCS, Infosys, HCL Tech, Wipro: Check Q3 results previews, price targets & more